Anxiety, depression, fatigue, and headache burden in the pediatric hydrocephalus population

Kathrin Zimmerman1, Bobby May2, Katherine Barnes1

  • 11Department of Neurosurgery, Division of Pediatrics; Departments of.

Insights

Children with hydrocephalus experience significant headache burdens, with more shunt surgeries correlating to worse headaches. Psychological issues like anxiety and depression are common but not linked to clinical factors.

Area of Science:

  • Pediatric Neurology
  • Neuroscience
  • Medical Psychology

Background:

  • Childhood hydrocephalus is a prevalent chronic condition affecting many children.
  • The impact of headache and psychological comorbidities in pediatric hydrocephalus remains under-researched.

Purpose of the Study:

  • To investigate the prevalence and severity of headache and psychological conditions in children with hydrocephalus.
  • To identify potential associations between clinical/demographic factors and these conditions.

Main Methods:

  • Utilized the Pediatric Migraine Disability Assessment (PedMIDAS) and Patient-Reported Outcomes Measurement Information System (PROMIS) for anxiety, depression, and fatigue.
  • Administered surveys to 40 children (ages 7+) during routine neurosurgery clinic visits.
  • Collected clinical and demographic data from medical records for correlational analysis.

Main Results:

  • 10% of children reported severe headache burden; a cluster of shunt operations was significantly associated with headache burden (p=0.003).
  • Mean PROMIS scores indicated an average burden of anxiety, depression, and fatigue compared to the general population.
  • No significant associations were found between child anxiety, depression, or fatigue and clinical or demographic variables.

Conclusions:

  • Children with hydrocephalus experience a notable burden of headache, anxiety, depression, and fatigue.
  • While multiple shunt operations correlate with increased headache burden, no specific clinical or demographic factors were linked to psychological comorbidities.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
609
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
176
Stress and Mental Health01:30

Stress and Mental Health

Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
393
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
343
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
156
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
153